JP2016519105A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519105A5 JP2016519105A5 JP2016507013A JP2016507013A JP2016519105A5 JP 2016519105 A5 JP2016519105 A5 JP 2016519105A5 JP 2016507013 A JP2016507013 A JP 2016507013A JP 2016507013 A JP2016507013 A JP 2016507013A JP 2016519105 A5 JP2016519105 A5 JP 2016519105A5
- Authority
- JP
- Japan
- Prior art keywords
- agents
- group formed
- agent
- synthesis
- cosmetically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000033115 angiogenesis Effects 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 102100028065 Fibulin-5 Human genes 0.000 claims description 2
- 101710170766 Fibulin-5 Proteins 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 28
- 239000003795 chemical substances by application Substances 0.000 claims 25
- 230000015572 biosynthetic process Effects 0.000 claims 17
- 238000003786 synthesis reaction Methods 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 10
- 229940079593 drug Drugs 0.000 claims 10
- 239000003112 inhibitor Substances 0.000 claims 6
- 239000002537 cosmetic Substances 0.000 claims 5
- -1 oleosome Substances 0.000 claims 5
- 210000003491 skin Anatomy 0.000 claims 5
- 210000001789 adipocyte Anatomy 0.000 claims 3
- 230000003796 beauty Effects 0.000 claims 3
- 239000000693 micelle Substances 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 239000000021 stimulant Substances 0.000 claims 3
- 125000006686 (C1-C24) alkyl group Chemical group 0.000 claims 2
- 102000010637 Aquaporins Human genes 0.000 claims 2
- 108010063290 Aquaporins Proteins 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 102000016942 Elastin Human genes 0.000 claims 2
- 108010014258 Elastin Proteins 0.000 claims 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 102000011990 Sirtuin Human genes 0.000 claims 2
- 108050002485 Sirtuin Proteins 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 230000001166 anti-perspirative effect Effects 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 239000003213 antiperspirant Substances 0.000 claims 2
- 230000015556 catabolic process Effects 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 238000006731 degradation reaction Methods 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 229920002549 elastin Polymers 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 230000003779 hair growth Effects 0.000 claims 2
- 210000002510 keratinocyte Anatomy 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 230000004130 lipolysis Effects 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000003223 protective agent Substances 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 239000002516 radical scavenger Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- NTQVODZUQIATFS-WAUHAFJUSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-methylbutanoic acid Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NTQVODZUQIATFS-WAUHAFJUSA-N 0.000 claims 1
- 102000008490 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Human genes 0.000 claims 1
- 108010020504 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Proteins 0.000 claims 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 claims 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 claims 1
- 235000007173 Abies balsamea Nutrition 0.000 claims 1
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 108090000991 Aquaporin 3 Proteins 0.000 claims 1
- 102100037332 Aquaporin-3 Human genes 0.000 claims 1
- 239000004857 Balsam Substances 0.000 claims 1
- 208000035985 Body Odor Diseases 0.000 claims 1
- 241000195940 Bryophyta Species 0.000 claims 1
- 208000035484 Cellulite Diseases 0.000 claims 1
- 108010009685 Cholinergic Receptors Proteins 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 230000033616 DNA repair Effects 0.000 claims 1
- 102000004237 Decorin Human genes 0.000 claims 1
- 108090000738 Decorin Proteins 0.000 claims 1
- 102000000541 Defensins Human genes 0.000 claims 1
- 108010002069 Defensins Proteins 0.000 claims 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 229940123457 Free radical scavenger Drugs 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 101001123331 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Proteins 0.000 claims 1
- 102000004157 Hydrolases Human genes 0.000 claims 1
- 108090000604 Hydrolases Proteins 0.000 claims 1
- 244000018716 Impatiens biflora Species 0.000 claims 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims 1
- 102000000536 PPAR gamma Human genes 0.000 claims 1
- 108010016731 PPAR gamma Proteins 0.000 claims 1
- 206010049752 Peau d'orange Diseases 0.000 claims 1
- 102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 claims 1
- 229940078467 Prolyl hydroxylase inhibitor Drugs 0.000 claims 1
- 229940123575 Protein synthesis stimulant Drugs 0.000 claims 1
- 102100037132 Proteinase-activated receptor 2 Human genes 0.000 claims 1
- 101710121435 Proteinase-activated receptor 2 Proteins 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 102000012479 Serine Proteases Human genes 0.000 claims 1
- 108010022999 Serine Proteases Proteins 0.000 claims 1
- 206010040904 Skin odour abnormal Diseases 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 102000034337 acetylcholine receptors Human genes 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000002293 adipogenic effect Effects 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 239000000809 air pollutant Substances 0.000 claims 1
- 229940061720 alpha hydroxy acid Drugs 0.000 claims 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims 1
- 235000008206 alpha-amino acids Nutrition 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 239000000921 anthelmintic agent Substances 0.000 claims 1
- 229940124339 anthelmintic agent Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003712 anti-aging effect Effects 0.000 claims 1
- 230000001760 anti-analgesic effect Effects 0.000 claims 1
- 230000002448 anti-glycating effect Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000002682 anti-psoriatic effect Effects 0.000 claims 1
- 230000001153 anti-wrinkle effect Effects 0.000 claims 1
- 239000000729 antidote Substances 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000003899 bactericide agent Substances 0.000 claims 1
- 239000000022 bacteriostatic agent Substances 0.000 claims 1
- 239000000440 bentonite Substances 0.000 claims 1
- 229910000278 bentonite Inorganic materials 0.000 claims 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims 1
- 150000001277 beta hydroxy acids Chemical class 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 229920001222 biopolymer Polymers 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 229940106189 ceramide Drugs 0.000 claims 1
- 150000001783 ceramides Chemical class 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 239000000812 cholinergic antagonist Substances 0.000 claims 1
- 239000000544 cholinesterase inhibitor Substances 0.000 claims 1
- 230000004087 circulation Effects 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 230000011382 collagen catabolic process Effects 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- 238000000280 densification Methods 0.000 claims 1
- 239000007854 depigmenting agent Substances 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000008298 dragée Substances 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000028023 exocytosis Effects 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 239000013003 healing agent Substances 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 230000035984 keratolysis Effects 0.000 claims 1
- 239000003410 keratolytic agent Substances 0.000 claims 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 125000001288 lysyl group Chemical group 0.000 claims 1
- 229920002521 macromolecule Polymers 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 230000008099 melanin synthesis Effects 0.000 claims 1
- 210000002752 melanocyte Anatomy 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 claims 1
- 230000004089 microcirculation Effects 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 235000011929 mousse Nutrition 0.000 claims 1
- 230000004118 muscle contraction Effects 0.000 claims 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000002088 nanocapsule Substances 0.000 claims 1
- 239000007908 nanoemulsion Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 239000002077 nanosphere Substances 0.000 claims 1
- 210000001577 neostriatum Anatomy 0.000 claims 1
- 230000001537 neural effect Effects 0.000 claims 1
- 239000002353 niosome Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229920000620 organic polymer Polymers 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 208000013823 pelvic organ prolapse Diseases 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000003711 photoprotective effect Effects 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 238000007634 remodeling Methods 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 claims 1
- 239000000932 sedative agent Substances 0.000 claims 1
- 230000001624 sedative effect Effects 0.000 claims 1
- 230000037307 sensitive skin Effects 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 230000037394 skin elasticity Effects 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 239000002047 solid lipid nanoparticle Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 210000000434 stratum corneum Anatomy 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 230000008728 vascular permeability Effects 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
- 231100000588 tumorigenic Toxicity 0.000 description 2
- 230000000381 tumorigenic effect Effects 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382138.9 | 2013-04-15 | ||
| EP13382138.9A EP2792684A1 (en) | 2013-04-15 | 2013-04-15 | Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions |
| PCT/EP2014/057672 WO2014170347A1 (en) | 2013-04-15 | 2014-04-15 | Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519105A JP2016519105A (ja) | 2016-06-30 |
| JP2016519105A5 true JP2016519105A5 (https=) | 2019-02-07 |
| JP6525433B2 JP6525433B2 (ja) | 2019-06-05 |
Family
ID=48227117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016507013A Active JP6525433B2 (ja) | 2013-04-15 | 2014-04-15 | 皮膚の処置および／またはケアにおいて有用な化合物ならびにその美容的または薬学的組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9458194B2 (https=) |
| EP (2) | EP2792684A1 (https=) |
| JP (1) | JP6525433B2 (https=) |
| KR (1) | KR102260346B1 (https=) |
| CN (1) | CN105408345B (https=) |
| AU (1) | AU2014255776B2 (https=) |
| CA (1) | CA2908863C (https=) |
| ES (1) | ES2639464T3 (https=) |
| WO (1) | WO2014170347A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486408B2 (en) * | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| WO2016063805A1 (ja) * | 2014-10-21 | 2016-04-28 | 日産化学工業株式会社 | レジスト下層膜形成組成物 |
| WO2016069396A2 (en) | 2014-10-31 | 2016-05-06 | Lubrizol Advanced Materials, Inc. | Thermoplastic polyurethane film for delivery of active agents to skin surfaces |
| CN114515269A (zh) * | 2015-04-06 | 2022-05-20 | 株式会社Lg生活健康 | 微针及其制造方法 |
| EP3371238A1 (en) | 2015-11-05 | 2018-09-12 | Lubrizol Advanced Materials, Inc. | Thermoformable dual network hydrogel compositions |
| EP3411012A4 (en) | 2016-02-04 | 2019-08-28 | Alastin Skincare, Inc. | COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKIN CARE |
| CN106176274B (zh) * | 2016-08-26 | 2020-04-10 | 深圳市维琪医药研发有限公司 | 一种具有抗敏作用的多肽组合物 |
| KR102471845B1 (ko) * | 2016-10-04 | 2022-11-28 | 마리 케이 인코포레이티드 | 튼살 치료를 위한 방법 및 조성물 |
| BR102017010169A2 (pt) * | 2017-05-15 | 2019-02-26 | Remer Consultores Assessoria Empresarial Ltda. | composto, intermediário de síntese, uso na preparação de anticonvulsivante, composição farmacêutica anticonvulsivante |
| MX2019005833A (es) | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
| WO2018101449A1 (ja) * | 2016-11-30 | 2018-06-07 | 株式会社資生堂 | 肌特性解析方法 |
| US12410143B2 (en) | 2017-01-17 | 2025-09-09 | Michael David FORREST | Therapeutic inhibitors of the reverse mode of ATP synthase |
| FR3065876B1 (fr) | 2017-05-05 | 2020-08-14 | Basf Beauty Care Solutions France Sas | Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses |
| BR112019028172A2 (pt) | 2017-07-13 | 2020-10-06 | Michael David Forrest | moduladores terapêuticos do modo reverso da atp sintase |
| KR102757675B1 (ko) * | 2017-08-03 | 2025-01-20 | 앨러스틴 스킨케어, 인크. | 피부 이완 및 신체 윤곽의 개선을 위한 조성물 및 방법 |
| CN108004282B (zh) * | 2017-12-01 | 2021-02-05 | 中国农业科学院麻类研究所 | 一种制备灵芝子实体发酵物的方法、发酵物及其应用 |
| WO2020028694A1 (en) | 2018-08-02 | 2020-02-06 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
| IT201900008364A1 (it) * | 2019-06-07 | 2020-12-07 | Espikem S R L | Peptidi bioattivi e composizioni che li comprendono |
| GB2586577B (en) * | 2019-06-14 | 2024-03-27 | Gelmetix Ltd | Diagnosis and treatment |
| CN111596069B (zh) * | 2020-06-03 | 2021-08-06 | 四川大学华西第二医院 | Hsp10在pop早期预警、诊断、预后评估中的应用和产品 |
| AU2021317264A1 (en) * | 2020-07-29 | 2022-09-22 | Karnak Technologies, Llc | Improved formulations of lipophilic subtances for cosmetic uses |
| EP4225345A4 (en) * | 2020-10-08 | 2024-12-04 | Alastin Skincare, Inc. | COMPOSITIONS AND METHODS FOR STIMULATION OF HYALURONIC ACID |
| US12223536B2 (en) * | 2020-10-19 | 2025-02-11 | Lillycover Co., Ltd. | Method for providing customized cosmetic product service |
| MX2023007788A (es) | 2021-01-24 | 2023-11-17 | Michael David Forrest | Inhibidores de la atp sintasa, usos cosmeticos y terapeuticos. |
| CN115670965B (zh) * | 2021-05-17 | 2024-04-19 | 杭州朝与暮品牌管理有限公司 | 一种有效抑制IL-8、TNF-α和IL-6的皮肤抗炎组合物 |
| FR3126309B1 (fr) * | 2021-08-30 | 2024-03-08 | Oreal | COMPOSITION COSMÉTIQUE à BASE DE GLAUCINE, RETINOL ET PEPTIDES POUR COMBATTRE LE VIEILLISSEMENT DE LA PEAU |
| CN113876641A (zh) * | 2021-11-05 | 2022-01-04 | 上海新高姿化妆品有限公司 | 一种具有抗皱紧致功效的化妆品组合物及其应用 |
| KR102792530B1 (ko) * | 2021-12-27 | 2025-04-08 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
| CN116120402B (zh) * | 2022-11-04 | 2024-03-15 | 深圳市维琪科技股份有限公司 | 一种环肽及其组合物和用途 |
| CN116987140A (zh) * | 2022-11-25 | 2023-11-03 | 深圳市维琪科技股份有限公司 | 具有抗衰老作用的肽及其组合物和用途 |
| CN116440019B (zh) * | 2023-03-27 | 2024-12-27 | 广东馨柯生命科学有限公司 | 含咖啡豆发酵液醒肤咖Supferm COFE和活力咖的防脱生发出水霜及其制备方法 |
| WO2024229256A1 (en) * | 2023-05-03 | 2024-11-07 | Glo Pharma, Inc. | Methods and compositions for cosmetic applications |
| CN117338628B (zh) * | 2023-12-05 | 2024-04-09 | 杭州湃肽生化科技有限公司 | 一种紧肤抗皱组合物及其应用 |
| CN119019504B (zh) * | 2023-12-26 | 2025-09-23 | 杭州湃肽生化科技有限公司 | 环五肽-4及其制备方法及应用 |
| WO2026029259A1 (ko) * | 2024-07-31 | 2026-02-05 | 주식회사 바이오비쥬 | 트로포엘라스틴 가교 활성을 갖는 생체 적합성 폴리머를 포함하는 조성물 |
| CN119462983B (zh) * | 2024-11-13 | 2025-09-23 | 成都大学 | 一种大枣改性酸性多糖及其制备方法和用途 |
| CN119241661B (zh) * | 2024-11-14 | 2025-08-01 | 云南贝泰妮生物科技集团股份有限公司 | 一种具有抗炎作用的环肽化合物及其制备方法和应用 |
| KR102782681B1 (ko) * | 2024-12-16 | 2025-03-19 | 주식회사 바이오비쥬 | 트로포엘라스틴 가교 활성을 갖는 생체 적합성 폴리머를 포함하는 기능성 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040126788A1 (en) | 2002-08-13 | 2004-07-01 | Schiemann William P. | Fibulin-5 and uses thereof |
| WO2005069975A2 (en) * | 2004-01-23 | 2005-08-04 | Massachusetts Eye & Ear Infirmary | Lysyl oxidase-like 1 (loxl1) and elastogenesis |
| WO2008152507A2 (en) | 2007-03-16 | 2008-12-18 | Multigene Vascular Systems, Inc. | Compositions and methods for treating ophthalmic disorders |
| EP2740484A1 (en) * | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions |
-
2013
- 2013-04-15 EP EP13382138.9A patent/EP2792684A1/en not_active Withdrawn
-
2014
- 2014-04-15 AU AU2014255776A patent/AU2014255776B2/en active Active
- 2014-04-15 KR KR1020157032617A patent/KR102260346B1/ko active Active
- 2014-04-15 JP JP2016507013A patent/JP6525433B2/ja active Active
- 2014-04-15 WO PCT/EP2014/057672 patent/WO2014170347A1/en not_active Ceased
- 2014-04-15 CN CN201480033925.4A patent/CN105408345B/zh active Active
- 2014-04-15 US US14/783,689 patent/US9458194B2/en active Active
- 2014-04-15 CA CA2908863A patent/CA2908863C/en active Active
- 2014-04-15 EP EP14717794.3A patent/EP2986626B1/en active Active
- 2014-04-15 ES ES14717794.3T patent/ES2639464T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016519105A5 (https=) | ||
| JP2019502677A5 (https=) | ||
| JP2016502550A5 (https=) | ||
| JP2015514721A5 (https=) | ||
| ES2198476T3 (es) | Inhibidores de no-sintasa. | |
| JP2015514124A5 (https=) | ||
| RU2012118581A (ru) | Пептиды, используемые в лечении и/или наблюдении за кожей, слизистыми оболочками и/или волосами, и их применение в косметических или фармацевтических композициях | |
| US20080275118A1 (en) | Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss | |
| JP2015514722A5 (https=) | ||
| JP2020500155A5 (https=) | ||
| JP2015514125A5 (https=) | ||
| EP2624806B1 (en) | Cosmetic skin care compositions comprising insoluble copper oxide | |
| JP2016535035A5 (https=) | ||
| JP2018500279A5 (https=) | ||
| US20080153839A1 (en) | Use of anisic acid for promoting desquamation | |
| CN104337705B (zh) | 含有葡糖酸内酯和乳糖酸的化妆品组合物 | |
| JP2013533226A5 (https=) | ||
| JP2011504894A (ja) | モチーフｇｘ１ｘ２ｇ、ｐｘ１ｘ２ｐ、またはｐｘ１ｘ２ｋを有するテトラペプチドを含有するパーソナルケアおよび化粧品組成物 | |
| JP2013544309A5 (https=) | ||
| CN101730689A (zh) | 6-酰氧基-7-甲氧基-2,2-二甲基色烷化合物和它们作为色素调节剂的用途 | |
| JP2006131633A (ja) | 皮膚の老化の徴候を抑制する尿素化合物の使用 | |
| FR2831441A1 (fr) | Utilisation cosmetique de derives de la dhea | |
| US20070043109A1 (en) | Slimming cosmetic composition | |
| JP2016527306A (ja) | 胆汁酸−脂肪酸抱合体を含む抗老化組成物 | |
| CN105496938B (zh) | α-红没药醇护肤液 |